Sectors
VNDA
Vanda Pharmaceuticals Inc.
5.40
1 x 4.37
1 x 5.78
bid
ask
+
0.11
2.08%
1 @ 07:30 PM
5.46 +0.06 (1.11%)
| Ytd | -38.78% | |
| 1y | 14.16% |
5.21
day range
5.45
4.27
52 week range
9.94
| Open | 5.23 | Prev Close | 5.29 | Low | 5.21 | High | 5.45 | Mkt Cap | 326.50M |
| Vol | 777.32K | Avg Vol | 925.21K | EPS | -4.64 | P/E | N/A | Forward P/E | 23.40 |
| Beta | 0.77 | Short Ratio | 4.85 | Inst. Own | 78.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 5.56 | 200-d Avg | 6.55 | 1yr Est | 10.43 |
| Income Statement | |||
| Total Revenue | 50.53M | ||
| Revenues (USD) | 50.53M | ||
| Cost of Revenue | 3.56M | ||
| Gross Profit | 46.97M | ||
| Operating Expenses | 110.78M | ||
| Research and Development Expense | 36.95M | ||
| Selling, General and Administrative Expense | 71.84M | ||
| Operating Income | -63.81M | ||
| Income Tax Expense | 129.00K | ||
| Net Income | -62.51M | ||
| Net Income Common Stock | -62.51M | ||
| Net Income Common Stock (USD) | -62.51M | ||
| Consolidated Income | -62.51M | ||
| Earnings per Basic Share | -1.04 | ||
| Earnings per Basic Share (USD) | -1.04 | ||
| Earnings per Diluted Share | -1.04 | ||
| Earning Before Interest & Taxes (EBIT) | -62.38M | ||
| Earning Before Interest & Taxes (USD) | -62.38M | ||
| Weighted Average Shares | 60.23M | ||
| Weighted Average Shares Diluted | 60.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.88M | ||
| Cash and Equivalents (USD) | 55.88M | ||
| Investments | 114.15M | ||
| Investments Current | 114.15M | ||
| Trade and Non-Trade Receivables | 59.69M | ||
| Current Assets | 264.48M | ||
| Property, Plant & Equipment Net | 23.95M | ||
| Total Assets | 412.47M | ||
| Total Debt | 18.20M | ||
| Current Liabilities | 164.03M | ||
| Debt Non-Current | 18.20M | ||
| Total Liabilities | 192.28M | ||
| Accumulated Retained Earnings (Deficit) | -505.85M | ||
| Accumulated Other Comprehensive Income | 38.00K | ||
| Shareholders Equity | 220.19M | ||
| Shareholders Equity (USD) | 220.19M | ||
| Assets Non-Current | 147.98M | ||
| Total Debt (USD) | 18.20M | ||
| Goodwill and Intangible Assets | 113.12M | ||
| Inventory | 12.60M | ||
| Liabilities Non-Current | 28.26M | ||
| Trade and Non-Trade Payables | 69.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.71M | ||
| Net Cash Flow from Financing | -856.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.85M | ||
| Capital Expenditure | -190.00K | ||
| Issuance (Repayment) of Debt Securities | -856.00K | ||
| Net Cash Flow from Investing | 33.81M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 34.00M | ||
| Net Cash Flow from Operations | -31.07M | ||
| Effect of Exchange Rate Changes on Cash | -36.00K | ||
| Share Based Compensation | 2.11M | ||